Gardasil Set For Further Growth As England Okays HPV Vaccine For Boys
Executive Summary
The decision to expand the HPV vaccination program in England to boys comes as Merck & Co sees "an unprecedented increase in global demand" for Gardasil.
You may also be interested in...
China Appetite For HPV Vaccine Delivers Surprise For Merck
When Merck realized that demand in China is so large for its HPV vaccine Gardasil, the US company wanted to understand more about the market, but a coordinated pre-launch awareness campaign appears to have helped.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Pharma Firms Welcome 'Pragmatic' EU Reforms But Concerns Persist
The European parliament has voted for legislation it says will lead to fairer, more accessible healthcare. The continent's drugmakers are still not wholly convinced.